rucaparib (rubraca) Report issue

Small molecule Orphan Drug FDA Approved FDA Accelerated Approval FDA Priority Review FDA
AACT ChEMBL DrugBank Drugs@FDA MeSH PubChem
Back

Drug Pricing Summary

VA Big4

$96.0387 - $96.9538

VA FSS

$116.2737

Drug Product Pricing

Product $/unit Ctry. List Type
Product (units) Manufacturer
rucaparib camsylate 200 mg (TABLET) $96.0387 VA Big4
  • Rubraca (60)
    		•  Clovis Oncology, Inc.
    rucaparib camsylate 200 mg (TABLET) $116.2737 VA FSS
  • Rubraca (60)
    		•  Clovis Oncology, Inc.
    rucaparib camsylate 250 mg (TABLET) $96.9538 VA Big4
  • Rubraca (60)
    		•  Clovis Oncology, Inc.
    rucaparib camsylate 250 mg (TABLET) $116.2737 VA FSS
  • Rubraca (60)
    		•  Clovis Oncology, Inc.
    rucaparib camsylate 300 mg (TABLET) $96.6353 VA Big4
  • Rubraca (60)
    		•  Clovis Oncology, Inc.
    rucaparib camsylate 300 mg (TABLET) $116.2737 VA FSS
  • Rubraca (60)
    		•  Clovis Oncology, Inc.

    Note: This drug pricing data is preliminary, incomplete, and may contain errors.

    Feedback

    Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

    Report issue